Home > Journals > Medicine > Médecine Thérapeutique médecine de la reproduction > summary
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
Médecine Thérapeutique / médecine de la reproduction
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
Printable version

HLA typing and preimplantation genetic diagnosis


Médecine Thérapeutique / médecine de la reproduction. Volume 8, Number 4, 273-80, Juillet-Août 2006, Revue

Free Article  

Author(s) : Hilde Van de Velde, Martine De Rycke, Ingeborg Liebaers

Summary : Typing of human leukocyte antigens (HLA) on preimplantation embryos is legally allowed and ethically accepted in Belgium. The ‘Vrije Universiteit Brussel’ (VUB) has five years of experience with technical and clinical aspects of HLA typing on single cells. Setting up and running a programme for HLA typing is labour intensive, in particular when it has to be combined with preimplantation genetic diagnosis (PGD) for distinct inherited genetic diseases, and time is always pressing because of the need for transplantation of the affected sibling. A general technique for HLA typing using short tandem repeats (STRs) linked to the HLA locus in multiplex PCR has been developed at our centre. At present, the overall clinical success rate is low: the ongoing pregnancy rate per oocyte retrieval cycle is 9.8%. This is not due to the technique because a conclusive HLA diagnosis can be assured in 91.9% of the embryos. The low success rate is correlated with a low transfer rate per cycle (35.5%). This is due to the genetic constitution of the embryos (in theory 1/4 for HLA, 1/8 for HLA in combination with sexing for X-linked recessive diseases and 3/16 for HLA in combination with autosomal recessive disorders) and clinical restrictions (in particular the reproductive age of the mother). The current ongoing pregnancy rate and implantation rate per transfer are acceptable (27.2% and 20.8% respectively). The results may be improved by selecting younger patients and by optimizing hormonal stimulation protocols and/or embryo culture systems.

Keywords : HLA typing, preimplanation genetic diagnosis, short tandem repeats

 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]